Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

PaperCitations, authors & open-access status

Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 61 citations, 2021 year and hybrid oa status.

61
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Li Wang
Author
Prostate Cancer Treatment and Research
Topic
Prostate Cancer Treatment and Research
Topic
Radiopharmaceutical Chemistry and Applications
Topic
Bone health and treatments
Topic
470M+ articles · free account